beta-Actin (8H10D10) Mouse Monoclonal An…
Ended Purchase order Nebraska Awarded
- Contract number
- 4800170539
- Awardee
- CELL SIGNALING TECHNOLOGY INC
- Contracting organization
- University of Nebraska
- Contract amount
- $353.00
Award facts
- Completion date
Award details come from statecontracts.nebraska.gov. Updated .
About this award
The University of Nebraska Medical Center (UNMC), located in Omaha, Nebraska, awarded a Purchase Order (PO) 4800170539 to Cell Signaling Technology Inc. of Boston, Massachusetts for a scientific research material. The contract, valued at $353.00, involves the procurement of one unit of beta-Actin (8H10D10) Mouse Monoclonal Antibody, identified by material number 3700S, to be delivered to UNMC's Shipping and Receiving department.
The contract's period of performance spans from January 14, 2026, to January 20, 2026, with delivery scheduled for January 20, 2026. The specific delivery location is designated as BCC 10.12.384, under the contact of Haitao Luan. The transaction is structured with Net 30 payment terms, F.O.B. destination, and freight prepaid, executed on behalf of the Board of Regents of the University of Nebraska and governed by the university's standard purchasing terms.
Line items
| Item | Total |
|---|---|
| beta-Actin (8H10D10) Mouse Monoclonal An… | $353.00 |
Files
| File | Type | Posted |
|---|---|---|
| 4800170539.pdf |
Quick answers
Who was awarded contract 4800170539?
Contract 4800170539 was awarded to CELL SIGNALING TECHNOLOGY INC by University of Nebraska on January 14, 2026.
How much is contract 4800170539 worth?
Its contract amount is $353.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award